LYMPHANGIOLEIOMYOMATOSIS (LAM) - QUESTIONS (Letter to the Editor and Response)
- A Szuba
- R Gupta
- FX McCormack
Abstract
Letter to the Editor and Response
Keywords: lymphangioleiomyomatosis (LAM), sporadic LAM, tuberous sclerosis LAM, vascular endothelial growth factors (VEGF), angiomyolipoma (AML), sirolimus (Rapamycin)
How to Cite:
Szuba, A., Gupta, R. & McCormack, F., (2015) “LYMPHANGIOLEIOMYOMATOSIS (LAM) - QUESTIONS (Letter to the Editor and Response)”, Lymphology 48(1), 51-52.
Downloads:
Download PDF